Mesothelioma
📧 Sign up to get email alerts when something new happens for Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Folinic Acid for Prevention of Pemetrexed-induced Toxicity [Phase 4]
Phase 4 trial update evaluating folinic acid to prevent pemetrexed-induced toxicity in NSCLC, mesothelioma, and thymoma.
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity [Phase 1, Phase 2]
Clinical trial exploring risk factors of immune checkpoint inhibitor–mediated liver, GI, endocrine, and skin toxicity across early-phase tri…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLC [Phase 2]
Phase 2 trial update for UNITO-001 in HRR/PD-L1 positive malignant pleural mesothelioma and non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Dose Individualization of Pemetrexed - IMPROVE-II [Phase 4]
Phase 4 trial update on dose individualization of pemetrexed (IMPROVE-II) has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Dose Individualization of Pemetrexed - IMPROVE-III [Phase 4]
Phase 4 trial update on dose individualization of pemetrexed (IMPROVE-III) completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases [Phase 1, Phase 2]
Phase 1/2 trial evaluating continuous 24-hour IV mithramycin for thoracic malignancies with pleuropulmonary metastases was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study results for INCB001158, an arginase inhibitor, as a single agent and in combination with immune checkpoint therapy, in patient…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma [Phase 2]
Phase II trial update for MEDI4736 (durvalumab) in combination with chemotherapy as first-line treatment for unresectable mesothelioma; stud…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM) [Phase 2]
Phase II trial update for Anetumab Ravtansine as second-line treatment in malignant pleural mesothelioma has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Mithramycin for Lung, Esophagus, and Other Chest Cancers [Phase 2]
Phase 2 trial of Mithramycin for lung, esophageal, and other chest cancers was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of CAR T cell therapy targeting mesothelin in metastatic cancer shows terminated status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma [Phase 1, Phase 2]
Phase 1/2 trial evaluating SS1P with pentostatin and cyclophosphamide for mesothelioma and related cancers has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy [Phase 2]
Phase 2 clinical trial update for intraperitoneal hyperthermic chemotherapy in several gynecologic and related cancers; current status not s…
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Nintedanib (BIBF 1120) in Mesothelioma [Phase 2, Phase 3]
Clinical trial updates for nintedanib in mesothelioma (Phase 2/3) with terminated status and posted results.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]
Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating the combination of sorafenib, pemetrexed, and cisplatin in patients with advanced solid tumors; the study is comple…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
This clinical trial update reports a completed study investigating whether genetic factors influence the risk of developing mesothelioma.
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies [NA]
Clinical trial update on early palliative care in advanced lung and gastrointestinal malignancies; status completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers [Phase 1]
Phase 1, single-dose pilot study evaluating radiolabeled amatuximab (MORAb-009) in mesothelin-overexpressing cancers has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer [Phase 1]
This Phase 1 clinical trial update reports on MORAb-009 in pancreatic cancer and mesothelioma, with related ovarian cancer and non-small cel…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) [NA]
A clinical trial evaluating CryoSpray Ablation for malignant airway disease in lung cancer and mesothelioma was terminated, with safety and …
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Comparison of the Ultra-low-dose Veo Algorithm With the Gold Standard Filtered Back Projection for Detecting Pulmonary Asbestos-related Conditions [Phase 4]
Phase 4 trial comparing the Ultra-low-dose Veo imaging algorithm with the gold-standard filtered back projection for detecting pulmonary asb…
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating eloxatin (oxaliplatin) plus gemcitabine for mesothelioma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy [Phase 2]
Phase 2 study evaluating cytoreductive surgery followed by heated intraperitoneal cisplatin and chemotherapy for peritoneal cancer; results …